Aura Minerals has set an IPO at $24.25 per share
Canadian Minerals priced 8.1 million common shares at $24.25 per share in the U.S. Early Public Offering (IPO).
The company plans to raise $194.4 million from its offering, as reported. Reuters.
Net revenue is allocated to initiatives that will strengthen your business. Acquisition of Mineraão Serra Grande (MSG), advances in development projects such as Era Dorada and Matupá, and expands mineral reserves through exploration.
The company has been approved to transfer its main list to the Nasdaq Global Select Market.
Early July 2025, the company He said he was preparing the list. Nasdaq stocks.
The underwriter has a 30-day option to purchase up to 1.2 million additional shares at the offering price.
The global coordinators for this offering are BOFA Securities and Goldman Sachs, with BTG Pactual and ItaúBBA being co-book runners.
Co-managers are Bradesco BBI, National Bank of Canada Financial Markets, RBC Capital Markets, and Scotia Bank.
Aura revealed that shareholders’ preemptive rights have been excluded according to company regulations. Brazilian deposit receipt holders regarding the public offering are not permitted preemptive rights.
This offer is not considered a Brazilian offer under local securities laws and regulations.
June 2025, Anglogold Ashanti A contract has been reached to sell MSG Mining shares In Goias, Brazil, we will go to Aura Minerals with a cash transaction of $76 million (R13.6 billion).
The Aura portfolio currently consists of five active mining operations: Minnosa Goldmine in Honduras, Armas, Apoena, Volvorema Goldmine in Brazil, and Alanzaz Mine in Mexico.
In addition to these production assets, the company is holding the ERA Dorada Gold Project and the Terrafria Gold Project in Colombia in Guatemala. Its Brazilian assets are the Matupá, the São Francisco project and the Carajás Copper project.
“Aura Minerals Sets an IPO at $24.25 per share” was originally created and published Mining Technologya brand owned by GlobalData.
The information on this site is contained in good faith for general information purposes only. It is not intended to be the advice you should resort to, and we will not give any representations, warranties or warranties, whether express or implied regarding its accuracy or completeness. You should seek expert or expert advice before taking or refraining from taking any medication based on the content on our site.